JPY 937.0
(0.43%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 8.31 Billion JPY | -58.44% |
2022 | 20 Billion JPY | 144.68% |
2021 | 8.17 Billion JPY | -53.55% |
2020 | 17.59 Billion JPY | 33.56% |
2019 | 13.17 Billion JPY | -42.07% |
2018 | 22.74 Billion JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 1.96 Billion JPY | -56.81% |
2023 Q4 | 4.54 Billion JPY | 148.82% |
2023 FY | 8.31 Billion JPY | -58.44% |
2023 Q3 | -9.31 Billion JPY | -476.92% |
2023 Q2 | 2.47 Billion JPY | 44.28% |
2023 Q1 | 1.71 Billion JPY | 219.8% |
2022 Q3 | 10.88 Billion JPY | 28.2% |
2022 Q1 | 2.04 Billion JPY | 112.88% |
2022 Q4 | -1.42 Billion JPY | -113.12% |
2022 FY | 20 Billion JPY | 144.68% |
2022 Q2 | 8.49 Billion JPY | 315.1% |
2021 FY | 8.17 Billion JPY | -53.55% |
2021 Q1 | 5.63 Billion JPY | 847.21% |
2021 Q3 | 10.52 Billion JPY | 33.09% |
2021 Q2 | 7.9 Billion JPY | 40.33% |
2021 Q4 | -15.88 Billion JPY | -251.01% |
2020 FY | 17.59 Billion JPY | 33.56% |
2020 Q2 | 7.78 Billion JPY | 724.4% |
2020 Q1 | -1.24 Billion JPY | 0.0% |
2020 Q3 | 11.82 Billion JPY | 51.93% |
2020 Q4 | -754 Million JPY | -106.38% |
2019 FY | 13.17 Billion JPY | -42.07% |
2018 FY | 22.74 Billion JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
DVx Inc. | 653.15 Million JPY | -1172.596% |
Seikagaku Corporation | 433 Million JPY | -1819.63% |
Eiken Chemical Co., Ltd. | 3.37 Billion JPY | -146.136% |
Create Medic Co., Ltd. | 803.24 Million JPY | -934.804% |
Techno Medica Co., Ltd. | 1.84 Billion JPY | -351.681% |
Rion Co., Ltd. | 3.47 Billion JPY | -139.202% |
Nihon Kohden Corporation | 19.59 Billion JPY | 57.575% |
Fukuda Denshi Co., Ltd. | 26.5 Billion JPY | 68.641% |
Japan Lifeline Co., Ltd. | 10.89 Billion JPY | 23.687% |
Japan Medical Dynamic Marketing, INC. | 1.74 Billion JPY | -375.81% |
3-D Matrix, Ltd. | -2.11 Billion JPY | 492.624% |
CYBERDYNE Inc. | -1.73 Billion JPY | 578.802% |